Canada's Apotex filed for approval of a Neulasta biosimilar in December and has also filed for approval of a Neupogen biosimilar that could be on the US market before the end of the year.

Stimufend ® (pegfilgrastim-fpgk), a biosimilar to Neulasta ® (pegfilgrastim), has been made available by Fresenius Kabi. Stimufend, a leukocyte growth factor, is indicated to decrease the ...

Coherus BioSciences plans to price its biosimilar of Amgen’s Neulasta, an infection-fighting treatment, at $4,175 per unit, according to Reuters. This is a 33 percent discount off the price of ...

On yesterday’s earnings call for Q4 2016, Amgen indicated that it is projecting its Neulasta® (pegfilgrastim) product to face biosimilar completion in the U.S. by the end of the year.

Amgen’s Neulasta is set to face its first competition in the US after the FDA approved Mylan’s biosimilar version of the blockbuster cancer infection biologic. Neulasta brought in $4.5 billion ...

a biosimilar version of Amgen’s Neulasta. Neulasta is the long-acting formulation of Neupogen, listed as filgrastim, which is taken by cancer patients undergoing chemotherapies in order to help ...

Coherus has agreed to sell its biosimilar Udenyca—which references Amgen’s febrile neutropenia drug Neulasta—to Intas Pharmaceuticals for up to $558.4 million. The deal, which is expected to ...

It’s a lab-created copy of a hormone that’s made naturally by your body. Neulasta is available in biosimilar forms. Biosimilars are like generic drugs. But unlike generics, which are made for ...

Since the Amgen v. Sandoz decision, Amgen and Sandoz have continued to litigate at the trial court level over Sandoz’s biosimilar versions of Neupogen and Neulasta. Based on recent court filings ...

Investigators concluded that reference or biosimilar pegfilgrastim could be ... the manufacturer of originator pegfilgrastim (Neulasta), recommend that pegfilgrastim injection be given to patients ...

Mylan's approval of its Neulasta biosimilar derisks management's 2H guidance and, importantly, demonstrates the company's ability to bring complex generics to market. Fulphila's success will ...

Credit: Getty Images. A biosimilar means that the biological product is approved based on data demonstrating that it is highly similar to an FDA-approved biological product. Fylnetra ...